Assessment of efficacy and safety of two modes of maintenance therapy with rabeprazole in patients with gastroesophageal reflux disease (GERD) of degrees 0 and 1
Minushkin, O.N.; Maslovskiĭ, L.V.; Anikina, N.I.; Shuleshova, A.G.
Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 29-35
2005
ISSN/ISBN: 1682-8658 PMID: 15932152 Document Number: 588034
Document emailed within 1 workday
Related Documents
Vasil'ev, I.V.; Noskova, K.K.; Zelenikin, S.A. 2002: Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage) Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 55-60; 190Semmanaselvan, K.; Mukaddam, Q.I.; Naik, M. 2015: An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease Journal of the Association of Physicians of India 63(7): 27-32
Kountouras, J.; Chatzopoulos, D.; Zavos, C.; Boura, P.; Venizelos, J.; Kalis, A. 2002: Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome Hepato-Gastroenterology 49(43): 193-197
Watanabe, Y. 2004: ENT manifestations of gastroesophageal reflux disease (GERD) Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1533-1536
Fan, Y.-H.; Lü, B.; Zhan, L.-X.; Zhang, L. 2007: Oesophageal acid exposure test in non-erosive gastroesophageal reflux disease and the diagnostic value of rabeprazole Zhonghua Nei Ke Za Zhi 46(6): 475-477
Khavkin, A.I.; Zhikhareva, N.S.; Rachkova, N.S.; Babaian, M.L.; Volynets, G.V.; Khanakaeva, Z.K. 2004: Particular features of application of proton pump inhibitors (Rabeprazole) in children with the gastroesophageal reflux disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 53-56
Chunlertrith, K.; Noiprasit, A.; Foocharoen, C.; Mairiang, P.; Sukeepaisarnjaroen, W.; Sangchan, A.; Sawadpanitch, K. 2014: GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis Clinical and Experimental Rheumatology 32(6 Suppl. 86): S
Habu, Y.; Yoshino, T.; Shio, S.; Hayakumo, T.; Kawai, K. 2004: Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1504-1509
Gómez-Escudero, O.; Remes-Troche, Jé.María.; Ruíz, J.Carlos.; Peláez-Luna, M.; Schmulson, M.Julio.; Valdovinos Díaz, M.Angel. 2004: Diagnostic usefulness of the Carlsson-Dent questionnaire in gastroesophageal reflux disease (GERD) Revista de Gastroenterologia de Mexico 69(1): 16-23
Maestri, L. 2001: Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 23(3-4): 187-189
Wurzer, H.; Schutze, K.; Bethke, T.; Fischer, R.; Luhmann, R.; Riesenhuber, C. 1999: Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group Hepato-Gastroenterology 46(27): 1809-1815
Taylor, D.M. 1984: Evaluation of the safety of metoclopramide in patients with gastroesophageal reflux disease Clinical Therapeutics 7(1): 28-32
Krolevets, T.S.; Livzan, M.A.; Lapteva, I.V. 2016: Gastroesophageal Reflux Disease in Overweight Various Degrees Eksperimental'naia i Klinicheskaia Gastroenterologiia 9: 19-26
Casale, M.; Sabatino, L.; Moffa, A.; Capuano, F.; Luccarelli, V.; Vitali, M.; Ribolsi, M.; Cicala, M.; Salvinelli, F. 2016: Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review European Review for Medical and Pharmacological Sciences 20(21): 4547-4552
Perotti, G.; Reale, F.; Pianesi, L.; Peschechera, R.; Andrisani, M.C.; Ciavarella, C.; Celi, G.; Maussier, M.L.; Valenza, V. 2004: Combined diagnostic imaging of upper gastrointestinal tract in a patient with dysphagia and suspected gastroesophageal reflux disease (GERD) Rays 29(2): 179-183
Danzig, J.; Navarro, R.; Inami, D.; Morreale, A.; Tokayer, A.; Wong, W.; Compton, J.; Page, R.N.; Sweet, F.B. 2001: The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion Managed Care Interface Suppl B: 13-20; Discussion 24-7 31-3
Hollander, D.; Karris, G. 1978: Efficacy of medical management of gastroesophageal reflux: a critical assessment Southern Medical Journal 71(Suppl): 41-42
Burduli, N.M.; Tadtaeva, D.I. 2012: Impact of laser therapy on PGE2 level, 24-hour pH-metry changes, and quality of life in patients with gastroesophageal reflux disease Terapevticheskii Arkhiv 84(12): 58-61
Gao, Y.; Shang, Z.-m.; Huang, W.-n.; Hao, J.-Y. 2011: A study of esophageal function and reflux characteristics of gastroesophageal reflux disease in patients presenting with chronic cough Zhonghua Nei Ke Za Zhi 50(11): 931-934
Shiino, Y.; Filipi, C.J.; Tomonaga, T.; Awad, Z.T.; Marsh, R.E. 2000: Does the duration of gastroesophageal reflux disease and degree of acid reflux correlate with esophageal function? A retrospective analysis of 768 patients Journal of Clinical Gastroenterology 30(1): 56-60